SCHEMBL32679588

SCHEMBL32679588

N[C@H](CO)c1cccc(-c2cccc(COc3ccccc3CC(=O)O)c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 18/20 1.00
F11 P03951 11/20 1.00
TPSB2 P20231 9/20 1.00
KLKB1 P03952 3/20 0.70
PLG P00747 2/20 0.70
PLAU P00749 2/20 0.70
F7 P08709 2/20 0.70
PTGER1 P34995 1/20 0.53
PTGER4 P35408 1/20 0.53
PTGER3 P43115 1/20 0.53
PTGER2 P43116 1/20 0.53
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
F2 P00734 1/20 0.49
F9 P00740 1/20 0.49
F10 P00742 1/20 0.49
PLAT P00750 1/20 0.49
PTGS1 P23219 1/20 0.49
SLC18A2 Q05940 1/20 0.49
PDE4D Q08499 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16396356 1.00 CFD (1.00) CFDF11TPSB2KLKB1PLG
SCHEMBL16396345 1.00 CFD (1.00) CFDF11TPSB2KLKB1PLG
SCHEMBL17764231 0.92 CFD (0.86) CFDF11TPSB2KLKB1PLG
SCHEMBL16396087 0.92 CFD (0.86) CFDF11TPSB2KLKB1PLG
SCHEMBL17764478 0.92 CFD (1.00) CFDF11TPSB2KLKB1PLG
SCHEMBL16397085 0.92 CFD (1.00) CFDF11TPSB2KLKB1PLG
SCHEMBL16396899 0.92 CFD (1.00) CFDF11TPSB2KLKB1PLG
SCHEMBL16396900 0.92 CFD (1.00) CFDF11TPSB2KLKB1PLG
SCHEMBL16410521 0.91 CFD (0.83) CFDF11TPSB2KLKB1PLG
SCHEMBL16397402 0.91 CFD (0.84) CFDF11TPSB2KLKB1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121570598-A Use of complement system inhibitors in the preparation of a medicament for the treatment of myeloma kidney disease 四川大学华西医院 2026-02-27 CN claimed
CN-121570598-A Use of complement system inhibitors in the preparation of a medicament for the treatment of myeloma kidney disease 四川大学华西医院 2026-02-27 CN disclosed